BRPI0612967B8 - método para a determinação in vitro da atividade de trombina em uma amostra biológica e kit - Google Patents

método para a determinação in vitro da atividade de trombina em uma amostra biológica e kit

Info

Publication number
BRPI0612967B8
BRPI0612967B8 BRPI0612967A BRPI0612967A BRPI0612967B8 BR PI0612967 B8 BRPI0612967 B8 BR PI0612967B8 BR PI0612967 A BRPI0612967 A BR PI0612967A BR PI0612967 A BRPI0612967 A BR PI0612967A BR PI0612967 B8 BRPI0612967 B8 BR PI0612967B8
Authority
BR
Brazil
Prior art keywords
sample
thrombin
kit
vitro determination
thrombin activity
Prior art date
Application number
BRPI0612967A
Other languages
English (en)
Inventor
Coenraad Hemker Hendrik
Giesen Peter
Al- Dieri Raed
Wagenvoord Robert
Nijhuis Sabastiaan
Beguin Suzette
Original Assignee
Synapse Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synapse Bv filed Critical Synapse Bv
Publication of BRPI0612967A2 publication Critical patent/BRPI0612967A2/pt
Publication of BRPI0612967B1 publication Critical patent/BRPI0612967B1/pt
Publication of BRPI0612967B8 publication Critical patent/BRPI0612967B8/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974Thrombin

Abstract

método para a determinação in vitro da atividade de trombina em uma amostra e kit. a presente invenção refere-se a um método para a determinação ín vitro da atividade da trombina em uma amostra, em que a amostra é uma amostra sanguínea e a geração da trombina é medida pelas etapas de: colocar uma camada de dita amostra em contato com um substrato fluorogênico da trombina, em que dita camada possui uma espessura dentro de um intervalo de 0,05 a 5 mm e uma superfície dentro de um intervalo de 10 a 500 mm2; permitir a geração de trombina em dita amostra; medir a fluorescência emitida a partir da superfície da camada, pelo grupo fluorescente liberado a partir do substrato fluorogênico como um resultado da ação enzimática da trombina gerada em dito substrato fluorogênico.
BRPI0612967A 2005-04-29 2006-04-26 método para a determinação in vitro da atividade de trombina em uma amostra biológica e kit BRPI0612967B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05290952A EP1717588A1 (en) 2005-04-29 2005-04-29 Measuring thrombin activity in whole blood
EP05290952.0 2005-04-29
PCT/EP2006/004945 WO2006117246A1 (en) 2005-04-29 2006-04-26 Measuring thrombin activity in whole blood

Publications (3)

Publication Number Publication Date
BRPI0612967A2 BRPI0612967A2 (pt) 2010-12-14
BRPI0612967B1 BRPI0612967B1 (pt) 2021-02-02
BRPI0612967B8 true BRPI0612967B8 (pt) 2021-07-27

Family

ID=34978991

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0612967A BRPI0612967B8 (pt) 2005-04-29 2006-04-26 método para a determinação in vitro da atividade de trombina em uma amostra biológica e kit

Country Status (16)

Country Link
US (1) US8916356B2 (pt)
EP (2) EP1717588A1 (pt)
JP (1) JP4897794B2 (pt)
KR (1) KR20080025043A (pt)
CN (1) CN101171519A (pt)
AR (1) AR053371A1 (pt)
AT (1) ATE483984T1 (pt)
AU (1) AU2006243283B2 (pt)
BR (1) BRPI0612967B8 (pt)
CA (1) CA2606906C (pt)
DE (1) DE602006017350D1 (pt)
ES (1) ES2354086T3 (pt)
MX (1) MX2007013497A (pt)
RU (1) RU2422835C2 (pt)
TW (1) TW200716982A (pt)
WO (1) WO2006117246A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090034860A (ko) * 2006-06-06 2009-04-08 드롬비노스코프 비.브이. 생물학적 매질에서 효소 활성을 측정하는 방법
ATE493505T1 (de) * 2006-11-02 2011-01-15 Thrombinoscope B V Verfahren zur messung der konzentration transienter proteolytischer aktivität in zellen enthaltenden zusammengesetzten biologischen medien
EP2088435B1 (en) 2008-02-07 2011-07-13 Synapse B.V. Time-course measurement of enzymatic activity corrected for impacts of disturbances relating to the reaction of the enzyme with a substrate
FR2933496B1 (fr) * 2008-07-02 2012-10-05 Lfb Biotechnologies Procede de mesure du taux de facteur vii active dans un echantillon
EP2316035A2 (en) * 2008-07-16 2011-05-04 Radiometer Medical ApS Thrombin substrate and assay for determining the level of bioactive thrombin in a sample
WO2010016762A1 (en) * 2008-08-05 2010-02-11 Synapse B.V. A method and assembly for measuring thrombin generation in plasma
JP5582745B2 (ja) * 2009-09-09 2014-09-03 メタウォーター株式会社 化学発光反応の時間計測による被検出物質の濃度を測定する方法およびそれに使用するキット
US8293493B2 (en) * 2010-01-27 2012-10-23 Adventist Health System/Sunbelt, Inc. Thrombin generation determination method
CN102798598A (zh) * 2011-05-25 2012-11-28 兆科药业(合肥)有限公司 一种检测磷脂依赖性凝血因子x激活物酶活性的方法
RU2518247C2 (ru) * 2011-07-26 2014-06-10 Общество с ограниченной ответственностью "ГемаКор Лабс" (ООО "ГемаКор Лабс") Способ определения пространственно-временного распределения активности протеолитического фермента в гетерогенной системе, устройство для реализации указанного способа и способ диагностики нарушений системы гемостаза по изменению пространственно-временного распределения активности протеолитического фермента в гетерогенной системе
JP6491880B2 (ja) 2011-08-23 2019-03-27 シナプス・ビー.ブイ.Synapse B.V. 異物表面との接触による血液凝固系の活性化の熱安定性阻害剤
CA2878568A1 (en) * 2011-12-31 2013-04-07 The University Of Vermont And State Agriculture College Methods for dynamic visualization of clinical parameters over time
KR101383333B1 (ko) * 2012-01-13 2014-04-10 연세대학교 산학협력단 트롬빈 생성 측정 방법
EP2677037B1 (en) 2012-06-21 2016-04-13 Synapse B.V. Simultaneous measurement of thrombin generation and clot strength in plasma and whole blood
JP6166279B2 (ja) 2012-12-18 2017-07-19 第一三共株式会社 トロンビン産生の測定方法
CN103185710B (zh) * 2013-02-04 2015-01-07 中国医学科学院输血研究所 人静脉注射免疫球蛋白中活化凝血因子ⅺ检测方法
CN104977259A (zh) * 2014-04-04 2015-10-14 天津药物研究院 一种基于高通量检测的血小板聚集测定方法及在药物筛选中的应用
US9986941B2 (en) 2014-06-26 2018-06-05 The Board Of Trustees Of The Leland Stanford Junior University Methods and apparatus for rapid monitoring of hemostatic state
CN104459165B (zh) * 2014-12-10 2016-07-06 中国医学科学院输血研究所 一种检测人凝血酶原复合物抗凝能力的方法
US10633645B2 (en) * 2015-12-30 2020-04-28 General Electric Company Calcium controlled activation of platelets via electrical stimulation
US10794896B2 (en) 2016-01-29 2020-10-06 Sony Corporation Blood coagulation system examination module, blood coagulation system examination system, blood coagulation system examination method, and determination method of parameter for blood coagulation system examination module
EP3363912B1 (en) 2017-02-17 2020-10-28 Synapse B.V. Self-calibrated assay for determining proteolytic enzyme generation, dedicated means and uses thereof
CN107102125B (zh) * 2017-04-17 2019-07-09 中国科学院苏州生物医学工程技术研究所 血栓弹力图仪的校准方法
RU2709341C1 (ru) * 2019-04-19 2019-12-17 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ПМ" Минздрава России) Определение циркулирующего тромбина в тесте активации системы комплемента
EP4004560A4 (en) * 2019-07-31 2022-11-30 Tel Hashomer Medical Research Infrastructure And Services Ltd. METHODS AND KITS FOR THROMBUS ORIGIN IDENTIFICATION AND POST-ISCHEMIC EVENT TREATMENT OPTIMIZATION
CN110412001B (zh) * 2019-08-01 2022-02-11 武汉塞力斯生物技术有限公司 一种动态监测凝血酶生成能力的试剂盒
CN110568117B (zh) * 2019-09-19 2022-03-22 青岛海洋生物医药研究院股份有限公司 一种多靶点抗血栓活性物质的液相色谱-质谱筛选方法
US20220193272A1 (en) 2020-12-21 2022-06-23 Ethicon, Inc. Bleeding Detection Method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55164356A (en) * 1979-06-08 1980-12-22 Fuji Photo Film Co Ltd Multi-layer analysis sheet for liquid sample analysis
CA2133983C (en) * 1992-04-27 2004-04-06 Stephen E. Zweig Test article and method for performing blood coagulation assays
AU2003232720B9 (en) * 2002-05-01 2009-12-03 Synapse B.V. Diagnostic test for determining the concentration of transient proteolytic activity in composite biological media

Also Published As

Publication number Publication date
ATE483984T1 (de) 2010-10-15
RU2422835C2 (ru) 2011-06-27
US20090311730A1 (en) 2009-12-17
CA2606906C (en) 2013-03-19
CA2606906A1 (en) 2006-11-09
TW200716982A (en) 2007-05-01
BRPI0612967A2 (pt) 2010-12-14
JP4897794B2 (ja) 2012-03-14
RU2007137972A (ru) 2009-06-10
MX2007013497A (es) 2008-04-04
ES2354086T3 (es) 2011-03-09
EP1875249A1 (en) 2008-01-09
AU2006243283A1 (en) 2006-11-09
AR053371A1 (es) 2007-05-02
JP2008539400A (ja) 2008-11-13
WO2006117246A1 (en) 2006-11-09
EP1717588A1 (en) 2006-11-02
DE602006017350D1 (de) 2010-11-18
KR20080025043A (ko) 2008-03-19
BRPI0612967B1 (pt) 2021-02-02
AU2006243283B2 (en) 2011-06-30
EP1875249B1 (en) 2010-10-06
US8916356B2 (en) 2014-12-23
CN101171519A (zh) 2008-04-30

Similar Documents

Publication Publication Date Title
BRPI0612967B8 (pt) método para a determinação in vitro da atividade de trombina em uma amostra biológica e kit
BRPI0907303A2 (pt) "artigos absorventes capazes de indicar a presença de urina"
BRPI0519570A2 (pt) mÉtodo de determinaÇço de faixa de dose de uma warfarina para um indivÍduo, kit para determinaÇço da faixa de dose de uma warfarina, oligonucleotÍdeo ou complemento do mesmo, e, arranjo de oligonucleotÍdeos
ES2530843T3 (es) Métodos basados en microARN para el diagnóstico de cáncer de páncreas
AR053272A1 (es) Determinacion de responsivos a la quimioterapia
IN2014DN04226A (pt)
ECSP11010831A (es) Compuestos orgánicos para la cicatrización de heridas
BR112012014925A2 (pt) compostos promotores de replicação de células beta e métodos de uso dos mesmos
GT200700077A (es) Compuestos de 4-metilpiridopirimidinona
UY32698A (es) Marcadores de riesgo para enfermedades cardiovasculares
DOP2011000050A (es) Inhibidores de cmet
BR112012009262A2 (pt) ''método para inibir a proliferação de células de câncer positivo para ar em um indivíduo diagnosticado com,ou qual se suspeita que tenha cânce positivo para ar e método para identificar se um indivíduo é um candidato para tratamento com uma composiçâo
BRPI0907317A2 (pt) composição farmacêutica e método para fabricar uma composição farmacêutica tópica em gel, espuma e em spray
BR112013003391A2 (pt) biomarcadores de câncer pancreático e usos dos mesmos
BR112014011935A2 (pt) elemento de cobertura, método e módulo de tratamento para tratar uma amostra biológica sobre um substrato
BRPI0607194B8 (pt) método e kit para analisar quantitativamente um microrganismo por marcação de rrna
BR112013006240A2 (pt) processo para detecção, diferenciação e quantificação de populações de células-t através da tecnologia quantitativa pcr (rt-qpcr) de transcrição reversa, em tempo real
TW200643425A (en) Probe card assembly and method of attaching probes to the probe carb assembly
WO2008150010A1 (ja) γ-セクレターゼの新規基質EphA4を利用したスクリーニング方法
ATE513217T1 (de) Verfahren zur steigerung der lichtemission einer chemilumineszenz-reaktion
ES2674177T3 (es) Preparación de suero
BR112014002823A2 (pt) processo para a medição de uma quantidade de enzimas digestivas liberadas de uma composição em um meio de dissolução e processo para a medição da quantidade de enzimas digestivas liberadas de uma composição sólida em meio de dissolução por espectroscopia de fluorescência combinado com um teste de gastrorresistência
BR112013004278A2 (pt) tintas de reagente enzimático para uso em tiras de teste tendo um código de calibração predeterminado
BR112012009527A2 (pt) dispositivo para detectar pelo menos um analito.
AR037870A1 (es) Metodo para determinar la actividad biologica de defibrotida

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/02/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/04/2006, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO